Scynexis (SCYX) Gains from Sales and Divestitures (2022 - 2026)

Scynexis (SCYX) reported Gains from Sales and Divestitures of $1.1 million for Q1 2026, up 10.62% on a YoY basis from $1.0 million in Q1 2025, and down 4.69% quarter-over-quarter from $1.2 million in Q4 2025.

Scynexis (SCYX) Gains from Sales and Divestitures (2022 - 2026) Analysis & Trends

Scynexis has reported Gains from Sales and Divestitures for 5 years, with the latest figure at $1.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Gains from Sales and Divestitures rose 10.62% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 10.62% YoY), and the FY2025 full-year result was $1.2 million, up 63.42% from the prior year.
  • Gains from Sales and Divestitures for Q1 2026 stood at $1.1 million, down from $1.2 million in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $1.2 million in Q4 2025, with the low at $48131.0 in Q3 2022.
  • Historically, Gains from Sales and Divestitures has averaged $636520.3 across 5 years, with a median of $629849.0 in 2024.
  • Annual changes were most pronounced in 2023 — Gains from Sales and Divestitures soared 516.67% — and 2026, when it advanced 10.62%.
  • Scynexis' Gains from Sales and Divestitures stood at $117831.0 in 2022, then jumped by 156.78% to $302561.0 in 2023, then jumped by 138.17% to $720599.0 in 2024, then surged by 63.42% to $1.2 million in 2025, then fell by 4.69% to $1.1 million in 2026.
  • The last three Gains from Sales and Divestitures figures came in at $1.1 million (Q1 2026), $1.2 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn
10 Scynexis 216.06 Mn 156.80 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.12 Mn
Mar 31, 2026 1.12 Mn
Dec 31, 2025 1.18 Mn
Dec 31, 2025 1.18 Mn
Sep 30, 2025 1.17 Mn
Sep 30, 2025 1.17 Mn
Jun 30, 2025 1.17 Mn
Jun 30, 2025 1.17 Mn
Mar 31, 2025 1.01 Mn
Mar 31, 2025 1.01 Mn
Dec 31, 2024 720,599.00
Dec 31, 2024 720,599.00
Sep 30, 2024 689,849.00
Sep 30, 2024 689,849.00
Jun 30, 2024 629,849.00
Jun 30, 2024 629,849.00
Mar 31, 2024 553,182.00
Mar 31, 2024 553,182.00
Dec 31, 2023 302,561.00
Dec 31, 2023 302,561.00